The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech Zealand Pharma’s “next generation” weight loss drug.
Related Posts
Walmart may have to raise some prices if Trump tariffs take effect, CFO says
The discounter’s comments are the latest warning from retail leaders about the potential impact of the tariffs.
It may be a good time for investors to look at less risky ways to stay in the stock market
Buffer and covered call funds may offer more predictable outcomes for investors amid choppy trading.
Fade the euphoria? Here’s what could go wrong with the Trump trade
Investors were spiking the ball in the end zone following Donald Trump’s stunning victory in this week’s presidential election.